RKLB
Good rocket, grumpy stock
Rocket Lab (NASDAQ: RKLB) did what Rocket Lab does: it launched another Electron mission, this time its 94th overall, and sent Synspective’s latest StriX Earth-imaging satellite into low Earth orbit from New Zealand. The mission also extended Rocket Lab’s 100% success rate for Synspective, which is neat if you like your space companies with a side of reliability.
But the chart is still the chart
The market, however, was not exactly throwing confetti. Shares slipped more than 1% to $61.81 even as the broader market nudged higher. The stock is still sitting well below its 20-day, 50-day, and 200-day moving averages, which is the financial equivalent of your car being in reverse while everyone else is merging onto the highway.
Launches help, but momentum is the boss
Rocket Lab said it has 16 more Electron missions booked to help Synspective expand its satellite constellation through 2030. That’s a solid backlog signal, and it tells you demand for the company’s launch services isn’t the issue.
What is still ugly? Momentum. The MACD remains below its signal line, the histogram is negative, and the stock’s longer-term technical setup is still flashing caution lights. In other words: the business is busy, but the stock wants proof before it stops sulking.
The setup from here
Analysts still like the name — the consensus is Buy, with an average price target around $110.71 — but the market clearly wants Rocket Lab to reclaim key technical levels before it starts believing again. If shares can push back above resistance near $67.50, that would be a much nicer story for the bulls.
Big picture: Rocket Lab keeps executing in orbit, but on Earth the stock is still fighting gravity.